Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

The FDA has approved oral semaglutide (Rybelsus) 7 mg and 14 mg tablets to lower the risk of cardiovascular death, heart attack, or stroke in high-risk adults with type 2 diabetes-marking the ...

A year after Novo Nordisk surrendered its pursuit of an approval in the U.S. for IcoSema as a treatment for Type 2 diabetes, the Danish company has scored a recommendation for the combination drug in ...

New guidance on preventing cardiovascular (CV) and renal complications in type 2 diabetes (T2D) emphasizes tailoring therapy to a patient’s individual risk profile. The living guidelines, published as ...

Lower blood sugar and increased fat burning – without negatively affecting appetite or muscle mass. These are some of the most promising effects of a new potential drug treatment for people with type ...

The company has announced positive data from the ACHIEVE-2 and ACHIEVE-5 trials, with both meeting all their primary and key ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Eli Lilly’s blockbuster ...

Metformin is a safe and effective oral medication for people with type 2 diabetes. Here's how it can help regulate ...

Use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors for the treatment of type 2 diabetes does not appear to increase the risk for urinary tract infections (UTIs) compared with two other new ...

An epidemic of Type 2 diabetes continues to plague the United States, leading to calls for reassessing how the disease is ...

Drugs widely used to treat type 2 diabetes may be more likely to keep working if they are used in moderation, researchers at Washington University School of Medicine in St. Louis have found in a study ...